000 01393 a2200421 4500
005 20250517030712.0
264 0 _c20160721
008 201607s 0 0 eng d
022 _a1477-0962
024 7 _a10.1177/0961203315583540
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRuinemans-Koerts, J
245 0 0 _aWhen to screen for lupus anticoagulant? Influence of testing during acute phase and consequences for clinical practise.
_h[electronic resource]
260 _bLupus
_cOct 2015
300 _a1233-5 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAcute-Phase Reaction
_xblood
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies, Antiphospholipid
_xanalysis
650 0 4 _aAntiphospholipid Syndrome
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLaboratory Proficiency Testing
650 0 4 _aLupus Coagulation Inhibitor
_xblood
650 0 4 _aMale
650 0 4 _aMass Screening
_xmethods
650 0 4 _aMiddle Aged
650 0 4 _aPractice Patterns, Physicians'
650 0 4 _aThrombosis
_xblood
700 1 _aAhmed-Ousenkova, Y M
700 1 _aKaasjager, H A H
700 1 _aHendriks-van Wijhe, C
700 1 _aHovens, M M C
773 0 _tLupus
_gvol. 24
_gno. 11
_gp. 1233-5
856 4 0 _uhttps://doi.org/10.1177/0961203315583540
_zAvailable from publisher's website
999 _c24843652
_d24843652